Short Interest in China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Declines By 36.4%

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) saw a large drop in short interest in November. As of November 15th, there was short interest totalling 67,000 shares, a drop of 36.4% from the October 31st total of 105,300 shares. Based on an average trading volume of 587,700 shares, the short-interest ratio is presently 0.1 days. Currently, 2.0% of the company’s stock are sold short.

China SXT Pharmaceuticals Price Performance

SXTC traded down $0.01 on Friday, reaching $0.40. The company had a trading volume of 26,716 shares, compared to its average volume of 715,651. China SXT Pharmaceuticals has a one year low of $0.37 and a one year high of $6.39. The company has a fifty day moving average of $0.55 and a 200-day moving average of $0.84. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.51 and a current ratio of 1.60.

China SXT Pharmaceuticals Company Profile

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.